Applying RFID in Pharma R&D (Smart Labels Europe 2005)

Dr William K Young, Principal Scientist
GlaxoSmithKline R&D, United Kingdom
 

Downloads

GSK Presentation*
GSK Audio*

If you already have access, please [Login]

Presentation Summary

This presentation is jointly given by Dr Bill Young, Principal Principal Scientist, and Jeff Veitch, Project Manager, GlaxoSmithKline, United Kingdom
 
  • The practical aspects, challenges and opportunities of RFID tagging within an R&D environment
  • With local memory and an unique serial number within each RFID label, there are opportunities to enhance existing processes or create new ones, which can reduce costs and increase accuracy
  • "Hey, there is a supply chain here..."
  • Examples from GSK R&D

Speaker CV

I am a Principal Scientist within a Concept Development Team. Previously, I was employed at the CRC Gray Laboratory, and had postdocs at Imperial College and University of East Anglia. I hold a Ph.D. in Physical Chemistry from Imperial College, London.

Company Profile

GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.
 
GSK's mission is to improve the quality of human life by enabling people to do more, feel better and live longer.
 
Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.
 
GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products.
 
The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders.
 
Based on 2004 Annual Results, GSK had sales of £20.3 billion ($37.2 billion) and profit before tax of £6.1 billion ($11.1 billion). Total pharmaceutical turnover was just over £17 billion ($31 billion) and consumer healthcare turnover was £3.2 billion ($5.8 billion).
 
GSK has over 100,000 employees worldwide. Of these, over 40,000 are in sales and marketing, the largest sales force in the industry. Around 35,000 employees work at 82 manufacturing sites in 37 countries and over 15,000 are in R&D.
 
GSK R&D is based at 24 sites in 11 countries. The company has a leading position in genomics/genetics and new drug discovery technologies. The GSK R&D budget is about £2.8bn/$5bn.

Upcoming Event

Smart Labels USA 2006
Westin Copley, Boston, MA
March 28-29, 2006
 
The fifth event in this series - in previous years over 400 people and 45 exhibitors have attended.